Clinical research
DOI: 10.4244/EIJ-D-23-00361
Safety and efficacy of the DragonFly system for transcatheter valve repair of degenerative mitral regurgitation: one-year results of the DRAGONFLY-DMR trial
Jian'an Wang1, MD, PhD; Xianbao Liu1, MD, PhD; Zhaoxia Pu1, MD; Mao Chen2, MD, PhD; Zhenfei Fang3, MD, PhD; Jun Jin4, MD; Jianzhen Dong5, MD, PhD; Yansong Guo6, MD, PhD; Biao Cheng7, MD; Jiancheng Xiu8, MD, PhD; Jianfang Luo9, MD; Yida Tang10, MD, PhD; Yan Wang11, MD, PhD; Xiaomen Chen12, MD, PhD; Gejun Zhang13, MD, PhD; Yibing Shao14, MD, PhD; Guangyuan Song15, MD, PhD; Lang Hong16, MD; Hong Jiang17, MD, PhD; Yangqin Wu18, MD, PhD; Yiqiang Yuan19, MD; Lianglong Chen20, MD, PhD; Ben He21, MD, PhD; Jingfeng Wang22, MD, PhD; Kai Xu23, MD; Yining Yang24, MD, PhD; Daxin Zhou25, MD, PhD; Qi Zhang26, MD, PhD; Yi Li27, MD; Kangmu Ma28, MD, PhD; Yat-Yin Lam29, MD; Yaling Han23, MD, PhD; Junbo Ge25, MD, PhD; D. Scott Lim30, MD; for the DRAGONFLYDMR Pivotal Trial Investigators
1. Department of Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 2. Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China; 3. Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, China; 4. Department of Cardiology, The Second Affiliated Hospital, Army Medical University, Chongqing, China; 5. Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 6. Department of Cardiology, Fujian Provincial Hospital, Fuzhou, China; 7. Department of Cardiology, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu, China; 8. Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; 9. Department of Cardiology, Guangdong Provincial People’s Hospital, Guangzhou, China and Guangdong Academy of Medical Sciences, Guangzhou, China; 10. Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China; 11. Department of Medicine, Xiamen University Cardiovascular Hospital, Xiamen, China; 12. Cardiology Center, Ningbo First Hospital, Ningbo, China; 13. Department of Cardiology, Fuwai Cardiovascular Hospital of Yunnan Province, Kunming, China; 14. Department of Cardiology, Qingdao Municipal Hospital, Qingdao, China; 15. Interventional Center of Valvular Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China; 16. Department of Cardiology, Jiangxi Provincial People’s Hospital, Nanchang, China and The First Affiliated Hospital of Nanchang Medical College, Nanchang, China; 17. Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China; 18. Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China; 19. Department of Cardiology, Henan Chest Hospital, Zhengzhou, China; 20. Department of Cardiology, Union Hospital, Fujian Medical University, Fuzhou, China; 21. Department of Cardiology, Shanghai Chest Hospital, Shanghai, China and Shanghai Jiao Tong University, Shanghai, China; 22. Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China; 23. Department of Cardiology, General Hospital of the Northern Theater of the Chinese People’s Liberation Army, Shenyang, China; 24. Department of Cardiology, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, China; 25. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China; 26. Department of Cardiology, Shanghai East Hospital, Shanghai, China and Tongji University, Shanghai, China; 27. The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; 28. Valgen Medtech, Hangzhou, China; 29. Hong Kong Asia Heart Centre, Canossa Hospital, Hong Kong, China; 30. Department of Medicine, University of Virginia Health System Hospital, Charlottesville, VA, USA